Biotech firm Crucell and US pharmaceuticals giant Wyeth are in friendly takeover talks, the Leiden-based firm confirmed on Thursday.
The Wall Street Journal says Wyeth has made a preliminary offer of $1.35bn for Crucell, but the company refused to comment. That price would represent a 32% premium on Crucell’s Wednesday closing price.
Crucell, which develops vaccines, made a profit for the first time in its 15-year history in the third quarter of last year, says the Financieele Dagblad.
Thank you for donating to DutchNews.nl.
We could not provide the Dutch News service, and keep it free of charge, without the generous support of our readers. Your donations allow us to report on issues you tell us matter, and provide you with a summary of the most important Dutch news each day.Make a donation